Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-01-10

FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Biocon Pharma Inc.,)

View source ↗

Summary

The FDA approved Biocon Pharma Inc.'s supplemental application for Esomeprazole Magnesium, a generic esomeprazole product, under ANDA 213486.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Esomeprazole magnesium (esomeprazole magnesium)

Snippet

SUPPL AP for ESOMEPRAZOLE MAGNESIUM (ESOMEPRAZOLE MAGNESIUM)